Canada Diabetes Care Devices Market Outlook to 2016-Aarkstore Enterprise Market Research Aggregation
Posted Jun 13 2010 10:26pm
Medical equipment offering, “Canada Diabetes Care Devices Market Outlook to 2016” provides key market data on the Canada diabetes care devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
- Market size and company share data for two diabetes care devices market categories – Glucose Monitoring and Insulin Delivery. - Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories. - Data from 2002 to 2009, forecast forward for 7 years to 2016. - 2009 company shares and distribution shares data for each of the two market categories. - Global corporate-level profiles of key companies operating within the Canada diabetes care devices market. Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Bayer HealthCare AG, Abbott Laboratories, Medtronic, Inc., Becton, Dickinson and Company and Novo Nordisk A/S.